Drug intelligence / Profile preview

Juanbi Qianggu Formula

Development stage
Unknown
Lead developer
Guanghua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
Administration
Oral
01

Overview

Juanbi Qianggu Formula (蠲痹強骨方) is a Traditional Chinese Medicine (TCM) herbal preparation developed by the Shanghai Guanghua Hospital of Integrated Traditional Chinese and Western Medicine. It is specifically formulated to treat musculoskeletal and inflammatory joint conditions, such as knee osteoarthritis and rheumatoid arthritis, particularly in patients presenting with the TCM syndrome of liver and kidney deficiency. The formula is designed to alleviate pain, reduce inflammation, and strengthen bone and cartilage structure. It has been evaluated in clinical trials as both a monotherapy and as an adjunct to conventional treatments like methotrexate and celecoxib.

Brand names
Juanbi Qianggu Granules
Other names
蠲痹強骨方Juanbi Qianggu Granules
02

Targets

miR-2683-3p (MicroRNA 2683-3p)RIPK2 (Receptor-interacting protein serine/threonine kinase 2)E3 ligase (E3 ubiquitin ligases)Long non-coding RNA ITSN1-2

Beyond the preview

Go deeper on Juanbi Qianggu Formula.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Juanbi Qianggu Formula.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call